For the combined strategy of enzyme/ADOR regulation and chemotherapy/radiotherapy, by using ADOR antagonists to block the inhibitory signals of ADO on immune cells, while combining with radiotherapy, chemotherapy, and oncolytic viruses (86), this strategy utilizes immunogenic cell death to release tumor antigens and activate adaptive immunity. The gene discussed is ADO; the disease is neoplasm.